Latest Event Updates
Drug Device Combination Products Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
This report studies the global market for drug device combination products from the perspective of product types. The market is thus segmented into drug eluting stents, infusion pumps, bone graft implants, photodynamic therapy, wound care combination devices, inhalers, transdermal patches and others including intraocular implants and drug eluting beads. The market for all these product segments is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD billion.
Browse the full report with complete TOC: http://www.transparencymarketresearch.com/drug-device-combination.html
Each of the segments have been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD billion, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.
A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for drug eluting stents and infusion pumps. A chapter on recommendations for existing and new entrants is also provided in this report.
Some of the major players profiled in this report are Boston Scientific Corporation, Abbott Laboratories, Allergan, Inc., Bayer Healthcare, Medtronic Inc., Bausch and Lomb, Inc. All these market players are profiled in this report via parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.
High incidence rates of chronic pain causing diseases, prostate cancer, diabetic retinopathy, cardiovascular diseases, colorectal cancer, asthma, obesity along with rapidly aging global population also form the key drivers for the global drug device combination products market. Government and NGO initiatives to promote drug delivery implants, rising number of interventional cardiologists and increase in the demand for minimally invasive surgeries are some of the other factors propelling the growth of the market. Introduction of biodegradable drug delivery technologies will serve as future growth opportunities for various drug device combination products. However, product recalls act as a major growth restraint for the market due to incidences such as adverse side effects to the patient. Also, these products form a challenge to FDA owing to their classification overlapping the regulated products and thus complicating their approval process.
Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019
Transparency Market Research is Published new Market Report “ Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019,” .The market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.
Browse the full report with complete TOC: http://www.transparencymarketresearch.com/nanomedicine-market.html
The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.
The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.
However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.
Browse full report with TOC: Nanomedicine Market – Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 – 2019
North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.
Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.
The global nanomedicine market is categorized into the following segments:
Nanomedicine Market by Application
Nanomedicine Market by Geography
- North America
- Rest of the World (RoW)
Browse more market research reports: Transparency Market Research
Biopreservation Market Expected to Reach USD 5.74 Billion Globally in 2019: Transparency Market Research
According to a new market report published by Transparency Market Research “Biopreservation Market (Product Types – Equipment, LIMS, and Media; Applications – Regenerative Medicine, Biobanking, and Drug Discovery) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,“theglobal biopreservation market was valued at USD 1.95billion in 2012 and is expected to reach a value of USD 5.74 billion in 2019, growing at a CAGR of 16.7% from 2013 to 2019.
Browse Biopreservation Market Report with Full TOC: http://www.transparencymarketresearch.com/biopreservation-market.html
Extensive undertaking of biomedical research for new drugs and therapies will be one of the major factors responsible for growth of the global biopreservation market. Use of stem cells, tissues, plasma and DNA in the research sector also requires adequate storage facilities to accommodate the growing number of samples, while also maintaining their stability. Increase in sample size will lead to rise in demand for equipment such as freezer, refrigerator, liquid nitrogen and consumables, along with media and laboratory information management systems (LIMS).In addition, increase in funding aimed at boosting the capacity for sample storage by the government as well as private institutions will expedite the introduction of new biopreservation facilities and hence will drive growth of the overall market. Other driving factors include rising incidences of cardiovascular, orthopedic, oncological, autoimmune and infectious diseases, rising population awareness and increase in the number of individual sample contributions.
The global biopreservation market by product type was dominated by the equipment segment with a market share of approximately 82% in 2012,on account of thehigh cost and demand from biobanks and in-house preservation facilities of pharmaceutical and biotechnology companies. Increase in the sample size will also result in the need for capacity expansion and so will lead to increase in demand for biopreservation equipment. However, the global market for biopreservation consumables will be the fastest growing product segment. Factors such as increased research and transnational activities will have a high demand for biological samples, which would also increase the demand for media solutions. The home-brew media segment held the majority share of over 72%in the total market for biopreservation media in 2012.
Browse full PDF with TOC: Biopreservation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
The global biopreservation market by applications was dominated by the biobanking segment with a market share of approximately 72% in 2012 on account of the high demand and usage of equipment, media and LIMS in this segment. Establishment of new biobanks during the forecast period will be one of the major growth factors for the biobanking application segment.However, the global regenerative medicine market for biopreservation will be the fastest growing application segment. A factor such as high prevalence of chronic diseases such as diabetes, rheumatoid arthritis, cardiac disorders and tumors is driving the regenerative medicine market which will result in increased demand for biopreservation media and equipment.
North America dominated the biopreservation market in 2012 and is expected to maintain its position till 2019. However, the Asia-Pacific market is estimated to grow at a faster CAGR of 19.6% from 2013 to 2019, due to increase in biobanking and research activities in the region. The European market is expected to grow at a fairly higher rate than North America,on account of the constantly improving infrastructure, regulatory framework and new biobanking projects, especially in the Eastern European region.
Some of the key players in the global biopreservation market include Thermo Fisher Scientific Inc., VWR International LLC, BioLife Solutions Inc., BioCision LLC, Biomatrica Inc., Qiagen, LABVANTAGE Solutions Inc. and Panasonic Corporation.
- Liquid Nitrogen (LN2) Tanks
- Laboratory Information Management Systems (LIMS)
- Home-brew Media
- Pre-formulated Media
- Regenerative Medicine
- Drug Discovery
- North America
- Rest of the World
Hospital Acquired Disease Testing Market Expected to Reach USD 7.5 Billion Globally in 2019: Transparency Market Research
According to a new market report published by Transparency Market Research “Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019″, the global hospital acquired disease testing market was valued at USD 2.2 billionin 2012 and is expected to grow at a CAGR of 19.3% from 2013 to 2019, to reach an estimated value of USD 7.5 billion in 2019.
Browse the full report with TOC: http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html
Nosocomial infections/hospital acquired diseases/hospital associated infections (HAI)form one of the critical areas of focus in the healthcare industry. Factors such as increasing prevalence of such conditions in neonatal and geriatric population, initiatives taken up by governments to manage nosocomial infections, increasing number of diseases that increases risk of hospital associated infections, and growing concerns about control and prevention of nosocomial infections worldwide will have a positive impact on the current hospital acquired disease testing industry.
The global hospital acquired disease testing market is segmented on the basis of type of infection and geography. Based on the different typesof infection,this market is classified into pneumonia, urinary tract infection, blood stream infection, surgical site associated infection, MRSA infection testing and others. The hospital acquired urinary tract infection diagnostics segment occupies the largest market share in this category as prevalence and morbidity rate of this condition, and the demand for diagnostic solutions for the same is the highest as compared to other hospital associated infections. It is expected that the global market for hospital associated urinary tract infection testing will reach USD 2,188.8 million in 2019 with the market growing at CAGR of 18.1%from 2013 to 2019. Furthermore, other testing solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America and other developing countries where the prevalence of such conditions is higher. It is expected that the market for surgical site infections will grow at a CAGR of 20.1%during the given period of forecast.
Geographically, United States and Canada together are the leaders in the global hospital acquired disease testing market with a combined market share (of the North American region) of 41.3% in 2012. Some of the major growth drivers for the North American nosocomial infection testing market include existence of highly developed healthcare infrastructure, high rate of implementation of healthcare guidelines given by regulatory and guiding institutions such as Centers for Disease Control and Prevention (U.S.), and increasing awareness about these diseases and their prevention. The European Union considers infectious diseases as an increasing threat to the general public health; the public health system in this region is increasingly engaging itself in conducting dialogue between healthcare providers and medical practitioners for developing better, faster and cost effective methods for nosocomial infection management and prevention. Asian countries including China, Philippines and India are the most potential markets for such diagnostic and testing solutions owing to existence of factors such as higher population, poor hospital infrastructure, lack of adherence to sanitation procedures and therefor higher disease prevalence growth rates. UAE and African countries are some of the lucrative markets in the Rest of the World (RoW).
Molecular diagnostics solutions play a vital role in this market as they offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers. Some of the key market players contributing to this industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.
The global hospital acquired disease testing market is segmented as follows:
Hospital Acquired Disease Testing Market, by Infection Type
- Pneumonia infection
- Urinary tract infection
- Blood stream associated infection
- Surgical site infection
- MRSA infection
Hospital Acquired Disease Testing Market, by Geography
- North America
- Rest of the World
New Released Report: Ultrasound Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2017
According to a new market report published by Transparency Market Research “ Ultrasound Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2017″ the global bone densitometers market was valued at USD 777.9 million in 2012 and is expected to grow at a CAGR of 3.3% from 2013 to 2019, to reach an estimated value of USD 908.5million in 2019.
Browse full report with TOC: http://www.transparencymarketresearch.com/ultrasound-market.html
Rise in the number of people suffering from chronic diseases is driving the demand for early diagnosis of disease, which is done through ultrasound. One of the primary applications of ultrasound is to produce images of human fetuses. The ultrasound market is expected to be at USD 4,817.8 million in 2012, which will reach USD 6,114.8 in 2017 at an estimated CAGR of 4.9% from 2012 to 2017.
Browse full PDF with TOC: Ultrasound Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2017
The Americas had the largest share in the ultrasound market, accounting for 38.5% in 2011 due to technological developments in ultrasound giving accurate results. The Americas will lead the market for gynecology ultrasound for the next five years.
Asia and countries of RoW such as South Africa and Egypt will exhibit the highest growth rate in the near future. Technological innovations in ultrasound are in an evolution phase in RoW. Rise in R&D investment by key players of healthcare and growth in medical tourism driven by low cost of healthcare services and investment of foreign players in the healthcare sector can enhance the ultrasound industry in RoW.
This report provides a holistic view to the overall global ultrasound industry with 8 year market data & forecast based on following segmentation:
- Gynecology ultrasound
- Cardiac ultrasound
- Vascular ultrasound
- RoW, which consists of Middle East and Africa
New Released Report: Global Breast Pumps Market Is Expected to Reach USD 1.03 Billion in 2018: Transparency Market Research
According to a new market report published by Transparency Market Research “Breast Pumps Market (Manual, Battery-powered and Electric Pumps) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018″ in 2011, the global breast pumps market was valued at USD 0.62 billion and is expected to grow at a CAGR of 7.5% from 2012 to 2018, to reach an estimated value of USD 1.03 billion in 2018.
Browse the full report with TOC: http://www.transparencymarketresearch.com/breast-pumps-market.html
The growth of this market is driven by the rising birth rates globally and the rapidly growing world population. With changing lifestyles and an increase in the number of working women, the consumer base for breast pumps is expanding and so is the demand for these devices. Restructuring of the reimbursement policies, which requires insurance companies to cover the cost of breastfeeding devices and lactation counseling, will also help improve the uptake of breast pumps. Increasing disposable incomes are strengthening the purchasing power of consumers and rising awareness about the benefits of breastfeeding will further help fuel market growth during the forecast period 2012 to 2018.
Electric pumps market is the fastest growing market segment with a CAGR of 11.9%. The preference for personal use electric pumps is expected to be the highest. In addition, the battery-powered pumps segment was the largest market segment in 2011 and will continue to be the leading segment till 2018, in terms of revenue.
Geographically, the North American region accounted for the largest market share in 2011. This is mainly due to the large consumer population, availability of advanced medical technologies, strong presence of leading market players and high purchasing power of consumers. However, with a high double digit CAGR of 17.1%, Asia will emerge as the fastest growing market due to the rapidly growing population, increasing awareness, rising disposable incomes and growing economies.
The global breast pumps market is highly consolidated and dominated by players such as Medela, Inc., Philips AVENT and Ameda Breastfeeding Solutions. Of these, Medela, Inc. accounted for the largest market share in 2011. Other small players in this market include Bailey Medical, Energizer Personal Care, LLC (Playtex Baby), Hygeia Medical Group, Lansinoh Laboratories, Inc. and Whittlestone, Inc.
The global breast pumps market is segmented as follows:
Breast Pumps Market, by Pumping System Type
- Personal Use
- Hospital Grade
Breast Pumps Market, by Product Design
- Open System Pumps
- Closed System Pumps
Biopsy Devices Market, by Geography
- North America
- Rest of the World (RoW)
Endometriosis Market: http://www.transparencymarketresearch.com/endometriosis-market.html
Medical Tourism Market: http://www.transparencymarketresearch.com/medical-tourism.html
X-Ray Market: http://www.transparencymarketresearch.com/x-ray-market.html